With the deepening of aging in China, cardiovascular diseases have become the number one killer endangering people's health, and primary hypertension is a high-risk major factor inducing cardiovascular diseases. The role played by traditional Chinese medicine in the treatment of hypertension is becoming more and more prominent, and the treatment is mostly based on calming the liver, removing blood stasis, resolving phlegm, and calming the wind. Due to modern lifestyle changes, phlegm and blood stasis have become the Main pathogenesis of vertigo. In his clinical practice, Dr. Fan Hong has formulated Tian Long Tong Luo Decoction for the treatment of primary hypertension, which mainly focuses on eliminating phlegm and freeing channels, supplemented by regulating other organs and emphasizing on prevention, and has gained good results in every case.

Tian Encheng, Fan Hong, Shen Haifei. Experience of Tianlong Tongluo Decoction in Treating Essential Hypertension Summary. Academic Journal of Medicine & Health Sciences (2023) Vol. 4, Issue 11: 60-67. https://doi.org/10.25236/AJMHS.2023.041109.

[1] Wang Zengwu. Epidemiology and management status of hypertension in China [J]. Chinese Journal of Cardiovascular Research, 2022, 20(08):673-678. 

[2] Chen Huijun, Liu Anjun, Zhang Yujia, et al. Research Progress of Essential Hypertension by TCM Characteristic Treatment [J]. Information on Traditional Chinese Medicine, 2021, 38(1):72-75. 

[3] Chao Yuanfang. A Treatise on the Origins and Currents of All Diseases [M]. Beijing: People's Military Medical Press, 2006:397. 

[4] Shan Shujian, Chen Zihua. Ancient and Modern Famous Doctors' Golden Guide on Headache and Vertigo [M]. Beijing: China Traditional Chinese Medicine Publishing House, 1999:63-70. 

[5] Lu Ying, et al. The Four Classics of Traditional Chinese Medicine [M]. Taiyuan: Shanxi Science and Technology Press, 2008. 1:245. 

[6] Zhang Jingyue. Jingyue Quanshu [M]. People's Health Publishing House, 1991:391-396.

[7] Chao Yuanfang, edited by Ding Guangdi, et al. The origin and symptoms of all diseases [M]. Beijing: People's Health Press, 2013:1021. 

[8] Zhu Danxi, Danxi Xinfa. Essence of Medical Books Integrating Ancient and Modern Books [M]. Shanxi Science and Technology Press, 1993:277-281. 

[9] Wang Kentang. Guidelines for evidence and treatment [M]. Beijing: People's Health Press, 2014:154. 

[10] Yang Shiying. Renzhai Zhi Zhiqi Fang Lun [M]. Fujian: Fujian Science and Technology Publication, 1989:78. 

[11] Gu Yubao, Liu Jingxia. Liu Jingxia’s Experience of Treating Hypertension by Drug Pairs [J]. Liaoning Journal of Traditional Chinese Medicine, 2018, 45(2):256-259. 

[12] Wang Lei, You Ke. Treatment of Senile Hypertension from Deficiency, Phlegm and Blood Stasis [J]. Clinical Journal of Traditional Chinese Medicine, 2017, 29(10):1647-1649. 

[13] Sun Yankang, Li Quanfang, Chen Lijuan. Primary hypertension from phlegm and stasis identification and treatment [J]. The Medical Forum, 2018, 22(11):1528-1530. 

[14] Han Xuejie, Liu Ying, Wang Liying, et al. Theorectical study on the relationship between hypertension and combined phlegm and blood stasis and f ive zang viscera [J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2009, 24(3):290-293.

[15] Wu Fang, Ding Lilin, Guan Xutao, et al. Observation of Huatan Huoxue Prescription Combined with Western Medicine for Primary Hypertension with Phlegm and Blood Stasis Type [J]. Journal of New Chinese Medicine, 2017, 49(12):17-20. 

[16] Huang Zhihui. Qutan Huoxue. Decoction combined with Levamlodipine Benzenesulfonate in the Treatment of Hypertension (Tanyu Hujie) [J]. Journal of Practical Traditional Chinese Internal Medicine, 2018, 32(8):55-58.

[17] Dong Caixia, Yin Shi'an. The role of lifestyle intervention in controlling hypertensive disease [J]. Overseas Medicine (Health Science Branch), 2009(6):387-390. 

[18] Chen Weiwei, Gao Runlin, Liu Lisheng, et al. Summary of the China Cardiovascular Disease Report 2017 [J]. Chinese Circulation Journal, 2018, 33(1):1-8. 

[19] Deng Yangsheng, Liu Quanwei, Zhao Zengguang. Cardiovascular disease-related risk levels among patients with essential hypertension [J]. China Journal of Modern Medicine, 2016(4):133-137. 

[20] Peng Li, Zhang Xuehua. Impact of lifestyle intervention on antihypertensive effect in community hypertensive patients [J]. Chinese Journal of Clinical Rehabilitation, 2004(12):2257, 2261. 

[21] Jia Xiaoya, Lao Wenwen, Shi Lipeng, et al. Summary of Experience in Treating Essential Hypertension Based on Phlegm and Blood Stasis Syndrome [J]. Journal of Practical Traditional Chinese Medicine, 2020, 36(02):259-260. 

[22] Zhou Zhongying, et al. Internal medicine of traditional Chinese medicine [M]. Beijing: China Press of Traditional Chinese Medicine, 2007:521. 

[23] Zhang Zhang, Qiu Le, Wang Hebao, et al. Discussion on the Form and Meaning of “Phlegm” in Traditional Chinese Medicine [J]. Journal of Traditional Chinese Medicine, 2019, 60(10): 811-814. 

[24] Dong Minghui. Progress of clinical application of Banxia Baizhu Tianma Decoction [J]. Chinese Journal of Ethnomedicine and Ethnopharmacy, 2012,21(3):44-44+46.